Skip to main content
. 2018 Jan 5;13(1):e0190883. doi: 10.1371/journal.pone.0190883

Table 1. Comparison of dose metrics for PTV and OARs.

Medians, 1st and 3rd quantiles of the metrics from a plan are listed for each treatment technique, p-value is from Mann-Whitney U test of the dose metric between synCT and CT plans.

4F O4F VMAT
synCT CT p-value synCT CT p-value synCT CT p-value
PTV D100% 93.2 92.7 0.53 92.1 92.2 1.00 86.2 86.5 0.77
(92.7, 93.4) (92.7, 93.2) (91.1, 92.5) (91.1, 92.5) (82.9, 87.5) (83.3, 87.7)
D95% 100.0 100.0 0.45 100.0 100.0 0.11 100.0 100.0 1.00
(100.0, 100.0) (100.0, 100.2) (100.0, 100.0) (100.0, 100.6) (100.0, 100.0) (99.7, 100.5)
D2% 105.3 106.1 0.72 107.9 107.9 0.72 107.1 107.4 0.16
(104.9, 107.1) (105.1, 107.0) (106.7, 108.9) (106.8, 109.4) (106.7, 107.3) (107.0, 108.1)
Dmean 103.2 103.5 0.24 104.4 104.6 0.39 103.1 103.2 0.35
(102.8, 103.4) (103.1, 104.0) (103.9, 104.6) (103.8, 105.1) (102.9, 103.3) (103.0, 103.7)
Bladder V40Gy 59.0 59.5 0.95 94.6 94.7 1.00 42.2 42.3 0.95
(35.4, 73.2) (35.4, 73.3) (87.4, 100.0) (87.3, 100.0) (25.6, 48.7) (26.0, 48.7)
Dmean 85.4 86.0 0.90 100.9 101.2 0.95 69.7 69.9 0.87
(75.4, 89.5) (75.3, 89.5) (97.6, 102.5) (97.8, 102.5) (63.0, 76.2) (63.4, 76.4)
Bowel V45Gy 19.5 19.7 0.97 62.6 62.9 1.00 8.5 8.8 0.91
(7.4, 45.2) (7.4, 45.2) (38.8, 73.0) (38.7, 72.9) (4.3, 27.0) (4.1, 26.9)
Femoral Head V30Gy 8.7 7.3 1.00 3.9 3.7 0.90 5.9 6.5 1.00
(2.2, 17.4) (2.2, 16.5) (2.2, 14.9) (2.0, 15.0) (3.4, 10.7) (3.4, 10.9)

Dmean: percentage mean dose relative to prescription dose